271 related articles for article (PubMed ID: 22022270)
21. Detection of virulence genes of Clostridium difficile by multiplex PCR.
Antikainen J; Pasanen T; Mero S; Tarkka E; Kirveskari J; Kotila S; Mentula S; Könönen E; Virolainen-Julkunen AR; Vaara M; Tissari P
APMIS; 2009 Aug; 117(8):607-13. PubMed ID: 19664132
[TBL] [Abstract][Full Text] [Related]
22. High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.
Curry SR; Marsh JW; Shutt KA; Muto CA; O'Leary MM; Saul MI; Pasculle AW; Harrison LH
Clin Infect Dis; 2009 Feb; 48(4):425-9. PubMed ID: 19140738
[TBL] [Abstract][Full Text] [Related]
23. [Antimicrobial susceptibilities and molecular characterization of toxin-positive Clostridium difficile isolates: the first report on the presence of hypervirulent strains from Turkey].
Salman E; Levent B; Karahan ZC
Mikrobiyol Bul; 2017 Jul; 51(3):236-246. PubMed ID: 28929960
[TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile toxin synthesis is negatively regulated by TcdC.
Dupuy B; Govind R; Antunes A; Matamouros S
J Med Microbiol; 2008 Jun; 57(Pt 6):685-689. PubMed ID: 18480323
[TBL] [Abstract][Full Text] [Related]
25. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
[No Abstract] [Full Text] [Related]
26. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1.
Akerlund T; Persson I; Unemo M; Norén T; Svenungsson B; Wullt M; Burman LG
J Clin Microbiol; 2008 Apr; 46(4):1530-3. PubMed ID: 18287318
[TBL] [Abstract][Full Text] [Related]
27. Predicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the key.
Stewart DB; Berg A; Hegarty J
J Gastrointest Surg; 2013 Jan; 17(1):118-24; discussion p.124-5. PubMed ID: 23086451
[TBL] [Abstract][Full Text] [Related]
28. New trends in Clostridium difficile virulence and pathogenesis.
Denève C; Janoir C; Poilane I; Fantinato C; Collignon A
Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565
[TBL] [Abstract][Full Text] [Related]
29. Rapid detection of the Clostridium difficile ribotype 027 tcdC gene frame shift mutation at position 117 by real-time PCR and melt curve analysis.
Wolff D; Brüning T; Gerritzen A
Eur J Clin Microbiol Infect Dis; 2009 Aug; 28(8):959-62. PubMed ID: 19333630
[TBL] [Abstract][Full Text] [Related]
30. Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens.
Wroblewski D; Hannett GE; Bopp DJ; Dumyati GK; Halse TA; Dumas NB; Musser KA
J Clin Microbiol; 2009 Jul; 47(7):2142-8. PubMed ID: 19403775
[TBL] [Abstract][Full Text] [Related]
31. Suppressive effect of Lactobacillus fermentum Lim2 on Clostridioides difficile 027 toxin production.
Yong CC; Lim J; Kim BK; Park DJ; Oh S
Lett Appl Microbiol; 2019 May; 68(5):386-393. PubMed ID: 30714187
[TBL] [Abstract][Full Text] [Related]
32. RstA Is a Major Regulator of Clostridioides difficile Toxin Production and Motility.
Edwards AN; Anjuwon-Foster BR; McBride SM
mBio; 2019 Mar; 10(2):. PubMed ID: 30862746
[No Abstract] [Full Text] [Related]
33. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
[TBL] [Abstract][Full Text] [Related]
34. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection.
Sloan LM; Duresko BJ; Gustafson DR; Rosenblatt JE
J Clin Microbiol; 2008 Jun; 46(6):1996-2001. PubMed ID: 18434563
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients.
Søes LM; Brock I; Persson S; Simonsen J; Pribil Olsen KE; Kemp M
Eur J Clin Microbiol Infect Dis; 2012 Feb; 31(2):185-92. PubMed ID: 21744281
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of toxigenic Clostridium difficile in a northern Italian hospital.
De Rosa FG; Cavallerio P; Corcione S; Parlato C; Fossati L; Serra R; Di Perri G; Cavallo R
Curr Microbiol; 2015 Feb; 70(2):154-5. PubMed ID: 25245958
[TBL] [Abstract][Full Text] [Related]
37. Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.
Secore S; Wang S; Doughtry J; Xie J; Miezeiewski M; Rustandi RR; Horton M; Xoconostle R; Wang B; Lancaster C; Kristopeit A; Wang SC; Christanti S; Vitelli S; Gentile MP; Goerke A; Skinner J; Strable E; Thiriot DS; Bodmer JL; Heinrichs JH
PLoS One; 2017; 12(1):e0170640. PubMed ID: 28125650
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of pathogenicity locus (PaLoc) and tcdC genetic diversity among tcdA
Kodori M; Ghalavand Z; Yadegar A; Eslami G; Azimirad M; Krutova M; Abadi A; Zali MR
Anaerobe; 2020 Dec; 66():102294. PubMed ID: 33181348
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods.
Spigaglia P; Mastrantonio P
J Med Microbiol; 2004 Nov; 53(Pt 11):1129-1136. PubMed ID: 15496392
[TBL] [Abstract][Full Text] [Related]
40. The flagellin FliC of Clostridium difficile is responsible for pleiotropic gene regulation during in vivo infection.
Barketi-Klai A; Monot M; Hoys S; Lambert-Bordes S; Kuehne SA; Minton N; Collignon A; Dupuy B; Kansau I
PLoS One; 2014; 9(5):e96876. PubMed ID: 24841151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
